多发性硬化皮层中β淀粉样蛋白与神经原纤维缠结减少的神经病理证据
该研究对死后多发性硬化(MS)患者(n=75)和对照(n=66)的颞叶与额叶皮层进行Aβ沉积和NFT密度检测,发现MS患者Aβ减少(尤其<65岁)且NFT减少(尤其>65岁),Aβ沉积可预测两组NFT密度增加。
要点
- MS病例较对照显示Aβ减少,尤其年龄<65岁者。
- MS病例较对照显示NFT减少,尤其年龄>65岁者。
- Aβ沉积可预测MS和对照中更高的NFT密度。
核心结论
- MS患者皮层Aβ沉积和NFT密度较对照减少,MS相关因素可能影响Aβ/NFT沉积和/或清除。
研究设计与样本
- 研究采用死后脑组织,检测颞叶和额叶皮层的Aβ沉积和NFT密度;MS组n=75,对照组n=66。
主要发现
- 与对照相比,MS病例显示Aβ减少,尤其在年龄<65岁的病例中;MS病例显示NFT减少,尤其在年龄>65岁的病例中。
- Aβ沉积可预测MS病例和对照中更高的NFT密度。
临床怎么用
- MS相关因素可能影响Aβ/NFT沉积和/或清除,为两种疾病提供新的治疗见解。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple sclerosis (MS) and Alzheimer's disease are neurodegenerative diseases with age-related disability accumulation. In MS, inflammation spans decades, whereas AD is characterized by Aβ plaques and neurofibrillary tangles (NFT). Few studies explore accumulation of amyloids in MS. We examined Aβ deposition and NFT density in temporal and frontal cortices from postmortem MS (n = 75) and control (n = 66) cases. Compared with controls, MS cases showed reduced Aβ, especially in those aged <65 years, and reduced NFT, notably in cases aged >65 years. Aβ deposition predicted greater NFT density both in MS cases and controls. MS-related factors may affect Aβ/NFT deposition and/or clearance, offering new therapeutic insights for both diseases. ANN NEUROL 2025;97:1067-1073.
引用
- Pansieri J, Pisa M, Yee S, et al. Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex. Ann Neurol. 2025. PMID: 40195794. doi:10.1002/ana.27231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。